NEW YORK, April 30 (Reuters) - The U.S. Securities and Exchange Commission is investigating trading of drugmaker Schering-Plough Corp (SGP.N) shares ahead of the announcement of its acquisition by U.S. rival Merck & Co Inc (MRK.N), the Wall Street Journal reported on Thursday, citing unnamed sources.
